Browsing Centre for Immunobiology by Subject "Safety"
Now showing items 1-1 of 1
-
Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study.
(Elsevier, 2023-10-06)BACKGROUND: Previous studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety ...